Clinical trials
Completed Tricuspid Valve Insufficiency trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Edwards Lifesciences | 4 |
| Mayo Clinic | 4 |
| Michele De Bonis | 3 |
| Universitaire Ziekenhuizen KU Leuven | 3 |
| Asan Medical Center | 2 |
| Heart and Diabetes Center North-Rhine Westfalia | 2 |
| Konkuk University Medical Center | 2 |
| Mitralix | 2 |
| P+F Products + Features GmbH | 2 |
| Rennes University Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tricuspid Valve Insufficiency | 51 |
| Mitral Valve Insufficiency | 10 |
| Heart Failure | 6 |
| Aortic Valve Stenosis | 3 |
| Cardiovascular Diseases | 3 |
| Heart Diseases | 3 |
| Heart Valve Diseases | 3 |
| Aortic Valve Insufficiency | 2 |
| Gastroesophageal Reflux | 2 |
| Mitral Valve Stenosis | 2 |
Trials
Showing 76 to 51 of 51. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.